行情

AXDX

AXDX

Accelr科技
NASDAQ

实时行情|Nasdaq Last Sale

16.21
+0.14
+0.87%
已收盘, 16:00 11/18 EST
开盘
15.93
昨收
16.07
最高
16.46
最低
15.93
成交量
20.92万
成交额
--
52周最高
24.00
52周最低
10.23
市值
8.86亿
市盈率(TTM)
-10.3525
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AXDX 新闻

  • 沪指低开高走 鲍威尔同特朗普及美财长会晤
  • 新浪财经.37分钟前
  • 泰国推“减塑”政策 商场超市等明年起不提供塑料袋
  • 中国新闻网.4小时前
  • 苹果“泰坦计划”又获新专利 可进行自动驾驶导航
  • 36氪.4小时前
  • 特朗普再次召见美联储主席讨论经济问题
  • 新华社.4小时前

更多

所属板块

先进医疗设备和技术
-0.99%
医疗设备和用品
-0.74%

热门股票

名称
价格
涨跌幅

AXDX 简况

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live bacterial or fungal cells are resistant or susceptible to a particular antibiotic. It detects and identifies pathogens directly from a single patient sample followed by antimicrobial susceptibility testing based on the identification results. The Accelerate PhenoTest BC Kit provides ID and AST results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The Accelerate Pheno system features walk-away automation and consists of a fixed instrument and single-use test kit.
展开

Webull提供Accelerate Diagnostics Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。